Published in Blood Weekly, September 27th, 1999
To determine the incidence of transfusion-associated HCV hepatitis, and of any residual transfusion-associated hepatitis (TAH) after HBsAg screening, R. Saxena and colleagues from New Delhi's G.B. Pant Hospital prospectively studied 182 patients who underwent surgery and received blood transfusion ("Transfusion-Associated Hepatitis in a Tertiary Referral Hospital in India," Vox Sang, August 1999;77(1):6-10).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.